Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,466,322
New position
Shares Held
9,801
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,795
of 4,153 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 84%
Shared 16%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Evelyn Partners Group Ltd holds $545,840,263 across 14 Drug Manufacturers - General names. ABBV ranks #4 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,237,205 | $424,218,810 | |
| 2 | JNJ |
Johnson & Johnson
|
297,561 | $75,571,565 | |
| 3 | LLY |
ELI LILLY & Co
|
30,954 | $37,127,157 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,801 | $2,466,322 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,867 | $1,910,408 | |
| 6 | NVO |
Novo Nordisk A S
|
36,496 | $1,749,618 | |
| 7 | PFE |
Pfizer Inc
|
66,194 | $1,593,950 | |
| 8 | SNY |
Sanofi
|
14,233 | $607,179 |
All Filings in ABBV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,466,322 | 9,801 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||